U.S. markets closed
  • S&P 500

    4,455.48
    +6.50 (+0.15%)
     
  • Dow 30

    34,798.00
    +33.18 (+0.10%)
     
  • Nasdaq

    15,047.70
    -4.54 (-0.03%)
     
  • Russell 2000

    2,248.07
    -10.97 (-0.49%)
     
  • Crude Oil

    73.95
    +0.65 (+0.89%)
     
  • Gold

    1,750.60
    +0.80 (+0.05%)
     
  • Silver

    22.42
    -0.26 (-1.16%)
     
  • EUR/USD

    1.1718
    -0.0029 (-0.25%)
     
  • 10-Yr Bond

    1.4600
    +0.0500 (+3.55%)
     
  • GBP/USD

    1.3681
    -0.0040 (-0.29%)
     
  • USD/JPY

    110.6850
    +0.3840 (+0.35%)
     
  • BTC-USD

    42,585.24
    +358.23 (+0.85%)
     
  • CMC Crypto 200

    1,067.20
    -35.86 (-3.25%)
     
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • Nikkei 225

    30,248.81
    +609.41 (+2.06%)
     

Herbalife Nutrition Shares Plummet After Lowering Q3, FY21 Outlook

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Herbalife Nutrition Ltd (NYSE: HLF) has revised its Q3 and FY21 guidance downwards. The company attributed the reduced Q3 and full-year net sales expectation to lower than expected activity levels amongst its independent distributors.

  • The nutrition company now expects a Q3 net sales decline of (6.5%) – (3.5%), versus its prior view for (1.0%) decline - 5.0% growth.

  • Q3 Adjusted EPS of $1.00 - $1.20 versus the prior view of $1.05 - $1.25, versus the consensus of $1.17.

  • Herbalife sees FY21 net sales growth of 4.5% - 8.5%, down from prior outlook for growth of 8.5% - 12.5%.

  • The company also updated full-year 2021 adjusted EPS guidance to $4.55 - $4.95 (prior $4.70 - $5.10), below the consensus of $4.99.

  • Adjusted full year EBITDA of $860 million - $910 million (prior $875 million - $935 million).

  • Herbalife expects to repurchase more than $200 million in shares in Q3 and Q4 s as part of the ongoing share repurchase program.

  • Price Action: HLF shares are trading lower by 19.67% at $43.57 on the last check Tuesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.